Cell and gene therapy claims are reshaping health stop-loss reinsurance. Learn how pipeline intelligence on multi-million-dollar therapies feeds stop-loss pricing, attachment points, and treaty design.
Diagnosis-level medical trend replaces the single blended assumption with granular claims analytics. Learn why health reinsurers now demand condition-specific trend rates for credible treaty pricing.
Drug-resistant fungal disease is an emerging infectious exposure health reinsurers cannot ignore. Learn how disease surveillance data reveals antifungal-resistance risk hiding in treaty portfolios.
Extreme heat drives health claims far beyond heatstroke. Learn how public-health surveillance data becomes treaty intelligence for pricing and reserving health reinsurance programs.
Healthcare fraud rings exploit fragmented claims review to compound losses. Learn how network analytics connects related fraudulent claims before they escalate into treaty-level recoveries.
Medical-record latency distorts health treaty experience by delaying accurate claims adjudication. Learn how faster record retrieval improves IBNR accuracy and treaty reserving.
Metabolic surgery reshapes health claims trajectories over years, not quarters. Learn how longitudinal claims data reveals the net cost effect for health reinsurance treaty pricing.
Provider contract renegotiation injects unit-cost shocks into health treaty experience. Learn how separating rate changes from utilisation trends sharpens reinsurance pricing at renewal.